相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical factors associated with worse quality-of-life scores in United States thyroid cancer survivors
Sneha Goswami et al.
SURGERY (2019)
Radioactive iodine in differentiated thyroid cancer: a national database perspective
Ryan K. Orosco et al.
ENDOCRINE-RELATED CANCER (2019)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
Hakim-Moulay Dehbi et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
Dehui Luo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
Martin Schlumberger et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer
Chi Yun Yu et al.
THYROID (2018)
Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer
Ju Hye Jeong et al.
NUCLEAR MEDICINE COMMUNICATIONS (2017)
Chinese Data of Efficacy of Low- and High-Dose Iodine-131 for the Ablation of Thyroid Remnant
Chao Ma et al.
THYROID (2017)
Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity
Nicholas S. Andresen et al.
EUROPEAN THYROID JOURNAL (2017)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Different Radioiodine Dose for Remnant Thyroid Ablation in Patients With Differentiated Thyroid Cancer A Meta-analysis
Xinghua Song et al.
CLINICAL NUCLEAR MEDICINE (2015)
Patterns of Use and Cost for Inappropriate Radioactive Iodine Treatment for Thyroid Cancer in the United States: Use and Misuse
Paolo Goffredo et al.
JAMA INTERNAL MEDICINE (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the con point of view
Livia Lamartina et al.
ENDOCRINE (2015)
The Impact of Postoperative Complications on Long-term Quality of Life After Curative Colorectal Cancer Surgery
Sarah R. Brown et al.
ANNALS OF SURGERY (2014)
Guidelines for the management of thyroid cancer
Petros Perros et al.
CLINICAL ENDOCRINOLOGY (2014)
Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: A meta-analysis
Jian Tu et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Effects of Low-Dose and High-Dose Postoperative Radioiodine Therapy on the Clinical Outcome in Patients with Small Differentiated Thyroid Cancer Having Microscopic Extrathyroidal Extension
Ji Min Han et al.
THYROID (2014)
Current Thyroid Cancer Trends in the United States
Louise Davies et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
High versus low radioiodine activity in patients with differentiated thyroid cancer: A meta-analysis
Antonis Valachis et al.
ACTA ONCOLOGICA (2013)
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients
Maria Grazia Castagna et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Papillary Thyroid Cancer: Time Course of Recurrences During Postsurgery Surveillance
Cosimo Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Low- or High-Dose Radioiodine Remnant Ablation for Differentiated Thyroid Carcinoma: A Meta-Analysis
Weiwei Cheng et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Well-differentiated thyroid carcinoma: The role of post-operative radioactive iodine administration
Supriya S. Patel et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma
Schelto Kruijff et al.
SURGERY (2013)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Pacini et al.
ANNALS OF ONCOLOGY (2012)
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
Ujjal Mallick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Radioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy Function
R. Michael Tuttle et al.
THYROID (2010)
Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study
Hanna O. Maenpaa et al.
PLOS ONE (2008)
Review: I-131 activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review
Allan Hackshaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Increasing incidence of thyroid cancer in the United States, 1973-2002
L Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer
AM Sawka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
